top of page
Search

Aries Biotech Partners with NeuroTheranostics, Inc.

Peptide-based Strategies for Healing Neurological Damage


Aries Biotech and NeuroTheranostics are merging their collective expertise in research and development to address potential impact of synthetic, protease-targeting compounds upon the central nervous system. These strategies have the potential to mitigate a broad spectrum of injuries and diseases.


To learn how we can assist with your needs within science and medicine, visit Aries Biotech at https://www.ariesbiotechnologies.org.

22 views0 comments

Recent Posts

See All

Honored to serve as a guest speaker for the Neuroscience Roadmap Scholars Program within the Department of Neurobiology, University of Alabama at Birmingham. A link to the UAB Neuroscience Program ma

Aries Biotech is pleased to announce new hours of operation! Effective 01 October 2022, hours of operation will be Monday-Thursday, 8am to 6pm (PST) by appointment. This change will help to accommod

bottom of page